Bentz Damholt, Birgitte http://orcid.org/0000-0002-0036-8345
Dombernowsky, Sarah Louise
Dahl Bendtsen, Mette http://orcid.org/0000-0003-2403-3520
Bisgaard, Charlotte
Højby Rasmussen, Michael http://orcid.org/0000-0002-2210-0366
Funding for this research was provided by:
Novo Nordisk
Article History
Accepted: 16 January 2021
First Online: 23 March 2021
Declarations
:
: Both trials were conducted in accordance with the 1964 Helsinki Declaration and its later amendments and ICH Good Clinical Practice. The study was approved by the appropriate health authorities and an independent Ethics Committee (i.e. a review panel responsible for ensuring the protection of the rights, safety, and well-being of human subjects involved in a clinical investigation).
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: These trials and publication fees (including open access) were sponsored by Novo Nordisk A/S.
: All authors confirm that they meet the International Committee of Medical Journal Editors (ICJME) uniform requirements for authorship and that they have contributed to critical analysis and interpretation of the data, drafting/critically revising the article, and sharing in the final responsibility for the content of the manuscript and the decision to submit the manuscript for publication.
: BBD, MDB, CB, and MHR are employed by and have shares in Novo Nordisk. SLD is employed by Novo Nordisk.
: Informed consent was obtained from all individual participants included in this study.
: Not applicable.
: Not applicable.